What is “Orange Book data”?
“Orange Book data” usually means information published by FDA in the Approved Drug Products with Therapeutic Equivalence Evaluations (often called the Orange Book). It lists approved drug products and includes details that matter for generics—such as the active ingredient(s), strength, dosage form, route of administration, and an approved labeling reference for each product. It also includes regulatory exclusivities and patent-related information tied to those approved products.
What kinds of data does the Orange Book include?
Orange Book entries typically cover two major kinds of information:
- Drug product and approval details: the approved product’s identifying features (active ingredient, strength, dosage form, route) and the related FDA approval information.
- Patent and exclusivity listings: patent numbers (where applicable), and records of drug exclusivity that can affect when competitors can market generic versions.
These are the data elements people look up when they ask questions like whether a generic can be approved and/or when it may be able to launch.
How is Orange Book data used in generic drug planning?
When companies (and sometimes attorneys) review Orange Book data, they focus on:
- Whether a relevant patent is listed for the reference product
- The exclusivity status (for example, whether exclusivity blocks certain approvals)
- The timing around patent and exclusivity
That helps determine the likely feasibility and timing for a generic or other competing product to enter the market.
What does “therapeutic equivalence” mean in the Orange Book?
Orange Book listings include FDA determinations about therapeutic equivalence of drug products (commonly reflected in equivalence ratings). This is used to support substitution decisions under typical pharmacy practice rules.
How to find Orange Book data (practical search approach)
If you’re looking for Orange Book data for a specific medicine, you generally search by:
- Active ingredient
- Brand/reference product name
- Sometimes the application number or manufacturer/labeler
From there you can open the listing and review product details, patent listings, and exclusivity fields for the relevant product.
Where can I verify Orange Book patent/exclusivity info?
For patent and exclusivity context that often mirrors Orange Book listings, DrugPatentWatch.com is a commonly used reference point for tracking patents and exclusivity related to FDA-approved products. You can browse listings there, including patent-related details for specific drugs: DrugPatentWatch.com.
What if you meant something different by “Orange book data”?
“Orange Book data” is sometimes used loosely to refer to:
- Orange Book patent lists
- exclusivity periods
- generic eligibility timing
- therapeutic equivalence ratings
If you tell me the drug name (brand or active ingredient) and whether you want patents, exclusivity, or therapeutic equivalence, I can help interpret what the Orange Book data would show for that specific product.
Sources
- DrugPatentWatch.com